| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.81B | 12.91B | 13.31B | 12.41B | 16.04B |
| Gross Profit | 9.56B | 10.34B | 10.68B | 9.65B | 10.38B |
| EBITDA | -1.43B | 9.94B | 10.24B | 9.12B | 9.21B |
| Net Income | -4.26B | 891.00M | 4.77B | -8.86B | 4.39B |
Balance Sheet | |||||
| Total Assets | 229.69B | 238.07B | 245.32B | 255.25B | 272.27B |
| Cash, Cash Equivalents and Short-Term Investments | 2.03B | 1.31B | 1.12B | 1.34B | 1.80B |
| Total Debt | 34.01B | 35.54B | 37.42B | 46.49B | 49.33B |
| Total Liabilities | 43.63B | 46.09B | 49.72B | 60.37B | 61.39B |
| Stockholders Equity | 181.71B | 187.82B | 191.41B | 190.36B | 206.11B |
Cash Flow | |||||
| Free Cash Flow | 6.73B | 6.30B | 5.82B | 6.65B | 7.77B |
| Operating Cash Flow | 6.77B | 6.34B | 5.87B | 6.69B | 7.97B |
| Investing Cash Flow | -61.00M | -174.00M | 7.17B | -2.16B | 199.00M |
| Financing Cash Flow | -6.01B | -5.96B | -13.25B | -4.90B | -8.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$106.91B | 11.54 | 25.39% | 2.92% | 5.89% | 9.36% | |
73 Outperform | HK$7.50B | 10.35 | 3.35% | 5.29% | -9.69% | -9.25% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | HK$46.52B | 23.45 | 1.35% | 5.92% | -11.49% | -20.93% | |
61 Neutral | HK$20.13B | 9.50 | 1.20% | 5.77% | 1.06% | 799.41% | |
58 Neutral | HK$73.90B | -17.53 | -2.32% | 5.04% | -0.75% | -577.88% | |
54 Neutral | HK$1.99B | -0.83 | -18.18% | 16.00% | -70.47% | 14.32% |